The first healthy volunteer has received a dose of a potential Covid-19 vaccine from researchers at Imperial College London.
The anonymous volunteer is reported to be in good health and being closely monitored after being injected on June 19. They will receive a booster within four weeks.
Dr Katrina Pollock, from Imperial’s Department of Infectious Disease and chief investigator of the study, said thousands of volunteers had signed up to be part of the vaccine studies.
"We have reached a significant milestone in this ground-breaking study with the first dose of a self-amplifying RNA vaccine delivered safely,” she said.
"We are now poised to test the vaccine in the dose evaluation phase before moving forward to evaluating it in larger numbers.”
Several other people are expected to receive the vaccination in the next few days. In the coming weeks, if the vaccine is safe and shows promise, another 300 participants will received two doses.
"We now eagerly await rapid recruitment to the trial so that we can assess both the safety of the vaccine and its ability to produce neutralising antibodies, which would indicate an effective response against Covid-19. I look forward to our progress in the coming months,” said Professor Robin Shattock from the Department of Infectious Disease at Imperial.
The vaccine is being supported with £41 million (£189m) in funding from the UK government and £5m (Dh23m) in charitable donations.
Another vaccine is being developed at Oxford University with pharmaceutical giant AstraZeneca.












